Advertisement

Index by author

June 01, 2002; Volume 30,Issue 6

A

  1. Alexson, Stefan E. H.

    1. Involvement of Liver Carboxylesterases in the In Vitro Metabolism of Lidocaine
      Stefan E. H. Alexson, Margareta Diczfalusy, Magnus Halldin and Stellan Swedmark
      Drug Metabolism and Disposition June 2002, 30 (6) 643-647; DOI: https://doi.org/10.1124/dmd.30.6.643

  2. Alvinerie, Michel

    1. Intestinal Secretion Is a Major Route for Parent Ivermectin Elimination in the Rat
      Céline M. Laffont, Pierre-Louis Toutain, Michel Alvinerie and Alain Bousquet-Mélou
      Drug Metabolism and Disposition June 2002, 30 (6) 626-630; DOI: https://doi.org/10.1124/dmd.30.6.626

  3. Anders, M. W.

    1. Immunohistochemical Localization and Activity of Glutathione Transferase Zeta (GSTZ1–1) in Rat Tissues
      Hoffman B. M. Lantum, Raymond B. Baggs, Daria M. Krenitsky, Philip G. Board and M. W. Anders
      Drug Metabolism and Disposition June 2002, 30 (6) 616-625; DOI: https://doi.org/10.1124/dmd.30.6.616

  4. Artur, Yves

    1. In Vitro Metabolism of Tresperimus by Human Vascular Semicarbazide-Sensitive Amine Oxidase
      Philippe Claud, Yves Artur and Romuald Laine
      Drug Metabolism and Disposition June 2002, 30 (6) 747-755; DOI: https://doi.org/10.1124/dmd.30.6.747

  5. Aviram, Michael

    1. The Licorice Root Derived Isoflavan Glabridin Inhibits the Activities of Human Cytochrome P450S 3A4, 2B6, and 2C9
      Ute M. Kent, Michael Aviram, Mira Rosenblat and Paul F. Hollenberg
      Drug Metabolism and Disposition June 2002, 30 (6) 709-715; DOI: https://doi.org/10.1124/dmd.30.6.709

B

  1. Backman, Janne T.

    1. Trimethoprim and Sulfamethoxazole are Selective Inhibitors of CYP2C8 and CYP2C9, Respectively
      Xia Wen, Jun-Sheng Wang, Janne T. Backman, Jouko Laitila and Pertti J. Neuvonen
      Drug Metabolism and Disposition June 2002, 30 (6) 631-635; DOI: https://doi.org/10.1124/dmd.30.6.631

  2. Baggs, Raymond B.

    1. Immunohistochemical Localization and Activity of Glutathione Transferase Zeta (GSTZ1–1) in Rat Tissues
      Hoffman B. M. Lantum, Raymond B. Baggs, Daria M. Krenitsky, Philip G. Board and M. W. Anders
      Drug Metabolism and Disposition June 2002, 30 (6) 616-625; DOI: https://doi.org/10.1124/dmd.30.6.616

  3. Baillie, Thomas A.

    1. The Disposition and Metabolism of Rofecoxib, a Potent and Selective Cyclooxygenase-2 Inhibitor, in Human Subjects
      Rita A. Halpin, Arturo G. Porras, Leslie A. Geer, Margaret R. Davis, Donghui Cui, George A. Doss, Eric Woolf, Donald Musson, Catherine Matthews, Ralph Mazenko, Jules I. Schwartz, Kenneth C. Lasseter, Kamlesh P. Vyas and Thomas A. Baillie
      Drug Metabolism and Disposition June 2002, 30 (6) 684-693; DOI: https://doi.org/10.1124/dmd.30.6.684

  4. Board, Philip G.

    1. Immunohistochemical Localization and Activity of Glutathione Transferase Zeta (GSTZ1–1) in Rat Tissues
      Hoffman B. M. Lantum, Raymond B. Baggs, Daria M. Krenitsky, Philip G. Board and M. W. Anders
      Drug Metabolism and Disposition June 2002, 30 (6) 616-625; DOI: https://doi.org/10.1124/dmd.30.6.616

  5. Bousquet-Mélou, Alain

    1. Intestinal Secretion Is a Major Route for Parent Ivermectin Elimination in the Rat
      Céline M. Laffont, Pierre-Louis Toutain, Michel Alvinerie and Alain Bousquet-Mélou
      Drug Metabolism and Disposition June 2002, 30 (6) 626-630; DOI: https://doi.org/10.1124/dmd.30.6.626

  6. Burchell, Brian

    1. Quantitative Structure Activity Relationships for the Glucuronidation of Simple Phenols by Expressed Human UGT1A6 and UGT1A9
      Brian T. Ethell, Sean Ekins, Jibo Wang and Brian Burchell
      Drug Metabolism and Disposition June 2002, 30 (6) 734-738; DOI: https://doi.org/10.1124/dmd.30.6.734

C

  1. Charasson, Virginie

    1. Determination of Drug Interactions Occurring with the Metabolic Pathways of Irinotecan
      Virginie Charasson, Marie-Christine Haaz and Jacques Robert
      Drug Metabolism and Disposition June 2002, 30 (6) 731-733; DOI: https://doi.org/10.1124/dmd.30.6.731

  2. Chung, Hye Chin

    1. Increase in Urea in Conjunction with l-Arginine Metabolism in the Liver Leads to Induction of Cytochrome P450 2E1 (CYP2E1): The Role of Urea in CYP2E1 Induction by Acute Renal Failure
      Hye Chin Chung, So Hee Kim, Myung Gull Lee and Sang Geon Kim
      Drug Metabolism and Disposition June 2002, 30 (6) 739-746; DOI: https://doi.org/10.1124/dmd.30.6.739

  3. Claud, Philippe

    1. In Vitro Metabolism of Tresperimus by Human Vascular Semicarbazide-Sensitive Amine Oxidase
      Philippe Claud, Yves Artur and Romuald Laine
      Drug Metabolism and Disposition June 2002, 30 (6) 747-755; DOI: https://doi.org/10.1124/dmd.30.6.747

  4. Cui, Donghui

    1. The Disposition and Metabolism of Rofecoxib, a Potent and Selective Cyclooxygenase-2 Inhibitor, in Human Subjects
      Rita A. Halpin, Arturo G. Porras, Leslie A. Geer, Margaret R. Davis, Donghui Cui, George A. Doss, Eric Woolf, Donald Musson, Catherine Matthews, Ralph Mazenko, Jules I. Schwartz, Kenneth C. Lasseter, Kamlesh P. Vyas and Thomas A. Baillie
      Drug Metabolism and Disposition June 2002, 30 (6) 684-693; DOI: https://doi.org/10.1124/dmd.30.6.684

D

  1. Davis, Margaret R.

    1. The Disposition and Metabolism of Rofecoxib, a Potent and Selective Cyclooxygenase-2 Inhibitor, in Human Subjects
      Rita A. Halpin, Arturo G. Porras, Leslie A. Geer, Margaret R. Davis, Donghui Cui, George A. Doss, Eric Woolf, Donald Musson, Catherine Matthews, Ralph Mazenko, Jules I. Schwartz, Kenneth C. Lasseter, Kamlesh P. Vyas and Thomas A. Baillie
      Drug Metabolism and Disposition June 2002, 30 (6) 684-693; DOI: https://doi.org/10.1124/dmd.30.6.684

  2. Diczfalusy, Margareta

    1. Involvement of Liver Carboxylesterases in the In Vitro Metabolism of Lidocaine
      Stefan E. H. Alexson, Margareta Diczfalusy, Magnus Halldin and Stellan Swedmark
      Drug Metabolism and Disposition June 2002, 30 (6) 643-647; DOI: https://doi.org/10.1124/dmd.30.6.643

  3. Doss, George A.

    1. The Disposition and Metabolism of Rofecoxib, a Potent and Selective Cyclooxygenase-2 Inhibitor, in Human Subjects
      Rita A. Halpin, Arturo G. Porras, Leslie A. Geer, Margaret R. Davis, Donghui Cui, George A. Doss, Eric Woolf, Donald Musson, Catherine Matthews, Ralph Mazenko, Jules I. Schwartz, Kenneth C. Lasseter, Kamlesh P. Vyas and Thomas A. Baillie
      Drug Metabolism and Disposition June 2002, 30 (6) 684-693; DOI: https://doi.org/10.1124/dmd.30.6.684

E

  1. Ekins, Sean

    1. Quantitative Structure Activity Relationships for the Glucuronidation of Simple Phenols by Expressed Human UGT1A6 and UGT1A9
      Brian T. Ethell, Sean Ekins, Jibo Wang and Brian Burchell
      Drug Metabolism and Disposition June 2002, 30 (6) 734-738; DOI: https://doi.org/10.1124/dmd.30.6.734

  2. Ethell, Brian T.

    1. Quantitative Structure Activity Relationships for the Glucuronidation of Simple Phenols by Expressed Human UGT1A6 and UGT1A9
      Brian T. Ethell, Sean Ekins, Jibo Wang and Brian Burchell
      Drug Metabolism and Disposition June 2002, 30 (6) 734-738; DOI: https://doi.org/10.1124/dmd.30.6.734

F

  1. Fan, Peter W.

    1. Characterization of Raloxifene Glucuronidation in Vitro: Contribution of Intestinal Metabolism to Presystemic Clearance
      Daniel C. Kemp, Peter W. Fan and Jeffrey C. Stevens
      Drug Metabolism and Disposition June 2002, 30 (6) 694-700; DOI: https://doi.org/10.1124/dmd.30.6.694

  2. Fujii, Toshihiko

    1. Hepatocyte Nuclear Factor-1α Is a Causal Factor Responsible for Interindividual Differences in the Expression of UDP-Glucuronosyltransferase 2B7 mRNA in Human Livers
      Kenji Toide, Yoshiki Takahashi, Hiroshi Yamazaki, Yoshiaki Terauchi, Toshihiko Fujii, Andrew Parkinson and Tetsuya Kamataki
      Drug Metabolism and Disposition June 2002, 30 (6) 613-615; DOI: https://doi.org/10.1124/dmd.30.6.613

G

  1. Geer, Leslie A.

    1. The Disposition and Metabolism of Rofecoxib, a Potent and Selective Cyclooxygenase-2 Inhibitor, in Human Subjects
      Rita A. Halpin, Arturo G. Porras, Leslie A. Geer, Margaret R. Davis, Donghui Cui, George A. Doss, Eric Woolf, Donald Musson, Catherine Matthews, Ralph Mazenko, Jules I. Schwartz, Kenneth C. Lasseter, Kamlesh P. Vyas and Thomas A. Baillie
      Drug Metabolism and Disposition June 2002, 30 (6) 684-693; DOI: https://doi.org/10.1124/dmd.30.6.684

  2. Glick, Stanley D.

    1. Metabolism of 18-Methoxycoronaridine, an Ibogaine Analog, to 18-Hydroxycoronaridine by Genetically Variable CYP2C19
      Wenjiang Zhang, Yamini Ramamoorthy, Rachel F. Tyndale, Stanley D. Glick, Isabelle M. Maisonneuve, Martin E. Kuehne and Edward M. Sellers
      Drug Metabolism and Disposition June 2002, 30 (6) 663-669; DOI: https://doi.org/10.1124/dmd.30.6.663

  3. Greenblatt, David J.

    1. In Vitro Biotransformation of Sildenafil (Viagra) in the Male Rat: The Role of CYP2C11
      Jill S. Warrington, Lisa L. von Moltke, Richard I. Shader and David J. Greenblatt
      Drug Metabolism and Disposition June 2002, 30 (6) 655-657; DOI: https://doi.org/10.1124/dmd.30.6.655

  4. Grobecker, Horst F.

    1. Comparison of Bioavailability and Metabolism with Two Commercial Formulations of Cyclosporine A in Rats
      Jens Koehler, Thomas Kuehnel, Frieder Kees, Klaus Hoecherl and Horst F. Grobecker
      Drug Metabolism and Disposition June 2002, 30 (6) 658-662; DOI: https://doi.org/10.1124/dmd.30.6.658

H

  1. Haaz, Marie-Christine

    1. Determination of Drug Interactions Occurring with the Metabolic Pathways of Irinotecan
      Virginie Charasson, Marie-Christine Haaz and Jacques Robert
      Drug Metabolism and Disposition June 2002, 30 (6) 731-733; DOI: https://doi.org/10.1124/dmd.30.6.731

  2. Halldin, Magnus

    1. Involvement of Liver Carboxylesterases in the In Vitro Metabolism of Lidocaine
      Stefan E. H. Alexson, Margareta Diczfalusy, Magnus Halldin and Stellan Swedmark
      Drug Metabolism and Disposition June 2002, 30 (6) 643-647; DOI: https://doi.org/10.1124/dmd.30.6.643

  3. Halpin, Rita A.

    1. The Disposition and Metabolism of Rofecoxib, a Potent and Selective Cyclooxygenase-2 Inhibitor, in Human Subjects
      Rita A. Halpin, Arturo G. Porras, Leslie A. Geer, Margaret R. Davis, Donghui Cui, George A. Doss, Eric Woolf, Donald Musson, Catherine Matthews, Ralph Mazenko, Jules I. Schwartz, Kenneth C. Lasseter, Kamlesh P. Vyas and Thomas A. Baillie
      Drug Metabolism and Disposition June 2002, 30 (6) 684-693; DOI: https://doi.org/10.1124/dmd.30.6.684

  4. Hoecherl, Klaus

    1. Comparison of Bioavailability and Metabolism with Two Commercial Formulations of Cyclosporine A in Rats
      Jens Koehler, Thomas Kuehnel, Frieder Kees, Klaus Hoecherl and Horst F. Grobecker
      Drug Metabolism and Disposition June 2002, 30 (6) 658-662; DOI: https://doi.org/10.1124/dmd.30.6.658

  5. Hollenberg, Paul F.

    1. The Licorice Root Derived Isoflavan Glabridin Inhibits the Activities of Human Cytochrome P450S 3A4, 2B6, and 2C9
      Ute M. Kent, Michael Aviram, Mira Rosenblat and Paul F. Hollenberg
      Drug Metabolism and Disposition June 2002, 30 (6) 709-715; DOI: https://doi.org/10.1124/dmd.30.6.709

K

  1. Kamataki, Tetsuya

    1. Hepatocyte Nuclear Factor-1α Is a Causal Factor Responsible for Interindividual Differences in the Expression of UDP-Glucuronosyltransferase 2B7 mRNA in Human Livers
      Kenji Toide, Yoshiki Takahashi, Hiroshi Yamazaki, Yoshiaki Terauchi, Toshihiko Fujii, Andrew Parkinson and Tetsuya Kamataki
      Drug Metabolism and Disposition June 2002, 30 (6) 613-615; DOI: https://doi.org/10.1124/dmd.30.6.613

  2. Kees, Frieder

    1. Comparison of Bioavailability and Metabolism with Two Commercial Formulations of Cyclosporine A in Rats
      Jens Koehler, Thomas Kuehnel, Frieder Kees, Klaus Hoecherl and Horst F. Grobecker
      Drug Metabolism and Disposition June 2002, 30 (6) 658-662; DOI: https://doi.org/10.1124/dmd.30.6.658

  3. Kemp, Daniel C.

    1. Characterization of Raloxifene Glucuronidation in Vitro: Contribution of Intestinal Metabolism to Presystemic Clearance
      Daniel C. Kemp, Peter W. Fan and Jeffrey C. Stevens
      Drug Metabolism and Disposition June 2002, 30 (6) 694-700; DOI: https://doi.org/10.1124/dmd.30.6.694

  4. Kent, Ute M.

    1. The Licorice Root Derived Isoflavan Glabridin Inhibits the Activities of Human Cytochrome P450S 3A4, 2B6, and 2C9
      Ute M. Kent, Michael Aviram, Mira Rosenblat and Paul F. Hollenberg
      Drug Metabolism and Disposition June 2002, 30 (6) 709-715; DOI: https://doi.org/10.1124/dmd.30.6.709

  5. Kim, Sang Geon

    1. Increase in Urea in Conjunction with l-Arginine Metabolism in the Liver Leads to Induction of Cytochrome P450 2E1 (CYP2E1): The Role of Urea in CYP2E1 Induction by Acute Renal Failure
      Hye Chin Chung, So Hee Kim, Myung Gull Lee and Sang Geon Kim
      Drug Metabolism and Disposition June 2002, 30 (6) 739-746; DOI: https://doi.org/10.1124/dmd.30.6.739

  6. Kim, So Hee

    1. Increase in Urea in Conjunction with l-Arginine Metabolism in the Liver Leads to Induction of Cytochrome P450 2E1 (CYP2E1): The Role of Urea in CYP2E1 Induction by Acute Renal Failure
      Hye Chin Chung, So Hee Kim, Myung Gull Lee and Sang Geon Kim
      Drug Metabolism and Disposition June 2002, 30 (6) 739-746; DOI: https://doi.org/10.1124/dmd.30.6.739

  7. Kobayashi, Tomo

    1. Imipramine N-Glucuronidation in Human Liver Microsomes: Biphasic Kinetics and Characterization of UDP-Glucuronosyltransferase Isoforms
      Miki Nakajima, Eriko Tanaka, Tomo Kobayashi, Noriko Ohashi, Toshiyuki Kume and Tsuyoshi Yokoi
      Drug Metabolism and Disposition June 2002, 30 (6) 636-642; DOI: https://doi.org/10.1124/dmd.30.6.636

  8. Koehler, Jens

    1. Comparison of Bioavailability and Metabolism with Two Commercial Formulations of Cyclosporine A in Rats
      Jens Koehler, Thomas Kuehnel, Frieder Kees, Klaus Hoecherl and Horst F. Grobecker
      Drug Metabolism and Disposition June 2002, 30 (6) 658-662; DOI: https://doi.org/10.1124/dmd.30.6.658

  9. Koetzner, Lee

    1. Characterization of Butyrylcholinesterase Antagonism of Cocaine-Induced Hyperactivity
      Lee Koetzner and James H. Woods
      Drug Metabolism and Disposition June 2002, 30 (6) 716-723; DOI: https://doi.org/10.1124/dmd.30.6.716
    2. Characterization of Equine Butyrylcholinesterase Disposition in the Mouse
      Lee Koetzner and James H. Woods
      Drug Metabolism and Disposition June 2002, 30 (6) 724-730; DOI: https://doi.org/10.1124/dmd.30.6.724

  10. Kohn, Michael C.

    1. Pharmacokinetics of Sodium Nitrite-Induced Methemoglobinemia in the Rat
      Michael C. Kohn, Ronald L. Melnick, Frank Ye and Christopher J. Portier
      Drug Metabolism and Disposition June 2002, 30 (6) 676-683; DOI: https://doi.org/10.1124/dmd.30.6.676

  11. Krenitsky, Daria M.

    1. Immunohistochemical Localization and Activity of Glutathione Transferase Zeta (GSTZ1–1) in Rat Tissues
      Hoffman B. M. Lantum, Raymond B. Baggs, Daria M. Krenitsky, Philip G. Board and M. W. Anders
      Drug Metabolism and Disposition June 2002, 30 (6) 616-625; DOI: https://doi.org/10.1124/dmd.30.6.616

  12. Kuehne, Martin E.

    1. Metabolism of 18-Methoxycoronaridine, an Ibogaine Analog, to 18-Hydroxycoronaridine by Genetically Variable CYP2C19
      Wenjiang Zhang, Yamini Ramamoorthy, Rachel F. Tyndale, Stanley D. Glick, Isabelle M. Maisonneuve, Martin E. Kuehne and Edward M. Sellers
      Drug Metabolism and Disposition June 2002, 30 (6) 663-669; DOI: https://doi.org/10.1124/dmd.30.6.663

  13. Kuehnel, Thomas

    1. Comparison of Bioavailability and Metabolism with Two Commercial Formulations of Cyclosporine A in Rats
      Jens Koehler, Thomas Kuehnel, Frieder Kees, Klaus Hoecherl and Horst F. Grobecker
      Drug Metabolism and Disposition June 2002, 30 (6) 658-662; DOI: https://doi.org/10.1124/dmd.30.6.658

  14. Kume, Toshiyuki

    1. Imipramine N-Glucuronidation in Human Liver Microsomes: Biphasic Kinetics and Characterization of UDP-Glucuronosyltransferase Isoforms
      Miki Nakajima, Eriko Tanaka, Tomo Kobayashi, Noriko Ohashi, Toshiyuki Kume and Tsuyoshi Yokoi
      Drug Metabolism and Disposition June 2002, 30 (6) 636-642; DOI: https://doi.org/10.1124/dmd.30.6.636

L

  1. Laffont, Céline M.

    1. Intestinal Secretion Is a Major Route for Parent Ivermectin Elimination in the Rat
      Céline M. Laffont, Pierre-Louis Toutain, Michel Alvinerie and Alain Bousquet-Mélou
      Drug Metabolism and Disposition June 2002, 30 (6) 626-630; DOI: https://doi.org/10.1124/dmd.30.6.626

  2. Laine, Romuald

    1. In Vitro Metabolism of Tresperimus by Human Vascular Semicarbazide-Sensitive Amine Oxidase
      Philippe Claud, Yves Artur and Romuald Laine
      Drug Metabolism and Disposition June 2002, 30 (6) 747-755; DOI: https://doi.org/10.1124/dmd.30.6.747

  3. Laitila, Jouko

    1. Trimethoprim and Sulfamethoxazole are Selective Inhibitors of CYP2C8 and CYP2C9, Respectively
      Xia Wen, Jun-Sheng Wang, Janne T. Backman, Jouko Laitila and Pertti J. Neuvonen
      Drug Metabolism and Disposition June 2002, 30 (6) 631-635; DOI: https://doi.org/10.1124/dmd.30.6.631

  4. Lantum, Hoffman B. M.

    1. Immunohistochemical Localization and Activity of Glutathione Transferase Zeta (GSTZ1–1) in Rat Tissues
      Hoffman B. M. Lantum, Raymond B. Baggs, Daria M. Krenitsky, Philip G. Board and M. W. Anders
      Drug Metabolism and Disposition June 2002, 30 (6) 616-625; DOI: https://doi.org/10.1124/dmd.30.6.616

  5. Lasseter, Kenneth C.

    1. The Disposition and Metabolism of Rofecoxib, a Potent and Selective Cyclooxygenase-2 Inhibitor, in Human Subjects
      Rita A. Halpin, Arturo G. Porras, Leslie A. Geer, Margaret R. Davis, Donghui Cui, George A. Doss, Eric Woolf, Donald Musson, Catherine Matthews, Ralph Mazenko, Jules I. Schwartz, Kenneth C. Lasseter, Kamlesh P. Vyas and Thomas A. Baillie
      Drug Metabolism and Disposition June 2002, 30 (6) 684-693; DOI: https://doi.org/10.1124/dmd.30.6.684

  6. Lee, Myung Gull

    1. Increase in Urea in Conjunction with l-Arginine Metabolism in the Liver Leads to Induction of Cytochrome P450 2E1 (CYP2E1): The Role of Urea in CYP2E1 Induction by Acute Renal Failure
      Hye Chin Chung, So Hee Kim, Myung Gull Lee and Sang Geon Kim
      Drug Metabolism and Disposition June 2002, 30 (6) 739-746; DOI: https://doi.org/10.1124/dmd.30.6.739

  7. Lin, Jiunn H.

    1. Effect of Albumin on Phenytoin and Tolbutamide Metabolism in Human Liver Microsomes: An Impact More Than Protein Binding
      Cuyue Tang, Yuh Lin, A. David Rodrigues and Jiunn H. Lin
      Drug Metabolism and Disposition June 2002, 30 (6) 648-654; DOI: https://doi.org/10.1124/dmd.30.6.648

  8. Lin, Yuh

    1. Effect of Albumin on Phenytoin and Tolbutamide Metabolism in Human Liver Microsomes: An Impact More Than Protein Binding
      Cuyue Tang, Yuh Lin, A. David Rodrigues and Jiunn H. Lin
      Drug Metabolism and Disposition June 2002, 30 (6) 648-654; DOI: https://doi.org/10.1124/dmd.30.6.648
    2. Inhibition Kinetics of Monoclonal Antibodies against Cytochromes P450
      Qin Mei, Cuyue Tang, Yuh Lin, Thomas H. Rushmore and Magang Shou
      Drug Metabolism and Disposition June 2002, 30 (6) 701-708; DOI: https://doi.org/10.1124/dmd.30.6.701

M

  1. Macha, Sreeraj

    1. Ocular Disposition of Ganciclovir and Its Monoester Prodrugs following Intravitreal Administration Using Microdialysis
      Sreeraj Macha and Ashim K. Mitra
      Drug Metabolism and Disposition June 2002, 30 (6) 670-675; DOI: https://doi.org/10.1124/dmd.30.6.670

  2. Maisonneuve, Isabelle M.

    1. Metabolism of 18-Methoxycoronaridine, an Ibogaine Analog, to 18-Hydroxycoronaridine by Genetically Variable CYP2C19
      Wenjiang Zhang, Yamini Ramamoorthy, Rachel F. Tyndale, Stanley D. Glick, Isabelle M. Maisonneuve, Martin E. Kuehne and Edward M. Sellers
      Drug Metabolism and Disposition June 2002, 30 (6) 663-669; DOI: https://doi.org/10.1124/dmd.30.6.663

  3. Matthews, Catherine

    1. The Disposition and Metabolism of Rofecoxib, a Potent and Selective Cyclooxygenase-2 Inhibitor, in Human Subjects
      Rita A. Halpin, Arturo G. Porras, Leslie A. Geer, Margaret R. Davis, Donghui Cui, George A. Doss, Eric Woolf, Donald Musson, Catherine Matthews, Ralph Mazenko, Jules I. Schwartz, Kenneth C. Lasseter, Kamlesh P. Vyas and Thomas A. Baillie
      Drug Metabolism and Disposition June 2002, 30 (6) 684-693; DOI: https://doi.org/10.1124/dmd.30.6.684

  4. Mazenko, Ralph

    1. The Disposition and Metabolism of Rofecoxib, a Potent and Selective Cyclooxygenase-2 Inhibitor, in Human Subjects
      Rita A. Halpin, Arturo G. Porras, Leslie A. Geer, Margaret R. Davis, Donghui Cui, George A. Doss, Eric Woolf, Donald Musson, Catherine Matthews, Ralph Mazenko, Jules I. Schwartz, Kenneth C. Lasseter, Kamlesh P. Vyas and Thomas A. Baillie
      Drug Metabolism and Disposition June 2002, 30 (6) 684-693; DOI: https://doi.org/10.1124/dmd.30.6.684

  5. Mei, Qin

    1. Inhibition Kinetics of Monoclonal Antibodies against Cytochromes P450
      Qin Mei, Cuyue Tang, Yuh Lin, Thomas H. Rushmore and Magang Shou
      Drug Metabolism and Disposition June 2002, 30 (6) 701-708; DOI: https://doi.org/10.1124/dmd.30.6.701

  6. Melnick, Ronald L.

    1. Pharmacokinetics of Sodium Nitrite-Induced Methemoglobinemia in the Rat
      Michael C. Kohn, Ronald L. Melnick, Frank Ye and Christopher J. Portier
      Drug Metabolism and Disposition June 2002, 30 (6) 676-683; DOI: https://doi.org/10.1124/dmd.30.6.676

  7. Mitra, Ashim K.

    1. Ocular Disposition of Ganciclovir and Its Monoester Prodrugs following Intravitreal Administration Using Microdialysis
      Sreeraj Macha and Ashim K. Mitra
      Drug Metabolism and Disposition June 2002, 30 (6) 670-675; DOI: https://doi.org/10.1124/dmd.30.6.670

  8. Musson, Donald

    1. The Disposition and Metabolism of Rofecoxib, a Potent and Selective Cyclooxygenase-2 Inhibitor, in Human Subjects
      Rita A. Halpin, Arturo G. Porras, Leslie A. Geer, Margaret R. Davis, Donghui Cui, George A. Doss, Eric Woolf, Donald Musson, Catherine Matthews, Ralph Mazenko, Jules I. Schwartz, Kenneth C. Lasseter, Kamlesh P. Vyas and Thomas A. Baillie
      Drug Metabolism and Disposition June 2002, 30 (6) 684-693; DOI: https://doi.org/10.1124/dmd.30.6.684

N

  1. Nakajima, Miki

    1. Imipramine N-Glucuronidation in Human Liver Microsomes: Biphasic Kinetics and Characterization of UDP-Glucuronosyltransferase Isoforms
      Miki Nakajima, Eriko Tanaka, Tomo Kobayashi, Noriko Ohashi, Toshiyuki Kume and Tsuyoshi Yokoi
      Drug Metabolism and Disposition June 2002, 30 (6) 636-642; DOI: https://doi.org/10.1124/dmd.30.6.636

  2. Neuvonen, Pertti J.

    1. Trimethoprim and Sulfamethoxazole are Selective Inhibitors of CYP2C8 and CYP2C9, Respectively
      Xia Wen, Jun-Sheng Wang, Janne T. Backman, Jouko Laitila and Pertti J. Neuvonen
      Drug Metabolism and Disposition June 2002, 30 (6) 631-635; DOI: https://doi.org/10.1124/dmd.30.6.631

O

  1. Ohashi, Noriko

    1. Imipramine N-Glucuronidation in Human Liver Microsomes: Biphasic Kinetics and Characterization of UDP-Glucuronosyltransferase Isoforms
      Miki Nakajima, Eriko Tanaka, Tomo Kobayashi, Noriko Ohashi, Toshiyuki Kume and Tsuyoshi Yokoi
      Drug Metabolism and Disposition June 2002, 30 (6) 636-642; DOI: https://doi.org/10.1124/dmd.30.6.636

P

  1. Parkinson, Andrew

    1. Hepatocyte Nuclear Factor-1α Is a Causal Factor Responsible for Interindividual Differences in the Expression of UDP-Glucuronosyltransferase 2B7 mRNA in Human Livers
      Kenji Toide, Yoshiki Takahashi, Hiroshi Yamazaki, Yoshiaki Terauchi, Toshihiko Fujii, Andrew Parkinson and Tetsuya Kamataki
      Drug Metabolism and Disposition June 2002, 30 (6) 613-615; DOI: https://doi.org/10.1124/dmd.30.6.613

  2. Porras, Arturo G.

    1. The Disposition and Metabolism of Rofecoxib, a Potent and Selective Cyclooxygenase-2 Inhibitor, in Human Subjects
      Rita A. Halpin, Arturo G. Porras, Leslie A. Geer, Margaret R. Davis, Donghui Cui, George A. Doss, Eric Woolf, Donald Musson, Catherine Matthews, Ralph Mazenko, Jules I. Schwartz, Kenneth C. Lasseter, Kamlesh P. Vyas and Thomas A. Baillie
      Drug Metabolism and Disposition June 2002, 30 (6) 684-693; DOI: https://doi.org/10.1124/dmd.30.6.684

  3. Portier, Christopher J.

    1. Pharmacokinetics of Sodium Nitrite-Induced Methemoglobinemia in the Rat
      Michael C. Kohn, Ronald L. Melnick, Frank Ye and Christopher J. Portier
      Drug Metabolism and Disposition June 2002, 30 (6) 676-683; DOI: https://doi.org/10.1124/dmd.30.6.676

R

  1. Ramamoorthy, Yamini

    1. Metabolism of 18-Methoxycoronaridine, an Ibogaine Analog, to 18-Hydroxycoronaridine by Genetically Variable CYP2C19
      Wenjiang Zhang, Yamini Ramamoorthy, Rachel F. Tyndale, Stanley D. Glick, Isabelle M. Maisonneuve, Martin E. Kuehne and Edward M. Sellers
      Drug Metabolism and Disposition June 2002, 30 (6) 663-669; DOI: https://doi.org/10.1124/dmd.30.6.663

  2. Robert, Jacques

    1. Determination of Drug Interactions Occurring with the Metabolic Pathways of Irinotecan
      Virginie Charasson, Marie-Christine Haaz and Jacques Robert
      Drug Metabolism and Disposition June 2002, 30 (6) 731-733; DOI: https://doi.org/10.1124/dmd.30.6.731

  3. Rodrigues, A. David

    1. Effect of Albumin on Phenytoin and Tolbutamide Metabolism in Human Liver Microsomes: An Impact More Than Protein Binding
      Cuyue Tang, Yuh Lin, A. David Rodrigues and Jiunn H. Lin
      Drug Metabolism and Disposition June 2002, 30 (6) 648-654; DOI: https://doi.org/10.1124/dmd.30.6.648

  4. Rosenblat, Mira

    1. The Licorice Root Derived Isoflavan Glabridin Inhibits the Activities of Human Cytochrome P450S 3A4, 2B6, and 2C9
      Ute M. Kent, Michael Aviram, Mira Rosenblat and Paul F. Hollenberg
      Drug Metabolism and Disposition June 2002, 30 (6) 709-715; DOI: https://doi.org/10.1124/dmd.30.6.709

  5. Rushmore, Thomas H.

    1. Inhibition Kinetics of Monoclonal Antibodies against Cytochromes P450
      Qin Mei, Cuyue Tang, Yuh Lin, Thomas H. Rushmore and Magang Shou
      Drug Metabolism and Disposition June 2002, 30 (6) 701-708; DOI: https://doi.org/10.1124/dmd.30.6.701

S

  1. Schwartz, Jules I.

    1. The Disposition and Metabolism of Rofecoxib, a Potent and Selective Cyclooxygenase-2 Inhibitor, in Human Subjects
      Rita A. Halpin, Arturo G. Porras, Leslie A. Geer, Margaret R. Davis, Donghui Cui, George A. Doss, Eric Woolf, Donald Musson, Catherine Matthews, Ralph Mazenko, Jules I. Schwartz, Kenneth C. Lasseter, Kamlesh P. Vyas and Thomas A. Baillie
      Drug Metabolism and Disposition June 2002, 30 (6) 684-693; DOI: https://doi.org/10.1124/dmd.30.6.684

  2. Sellers, Edward M.

    1. Metabolism of 18-Methoxycoronaridine, an Ibogaine Analog, to 18-Hydroxycoronaridine by Genetically Variable CYP2C19
      Wenjiang Zhang, Yamini Ramamoorthy, Rachel F. Tyndale, Stanley D. Glick, Isabelle M. Maisonneuve, Martin E. Kuehne and Edward M. Sellers
      Drug Metabolism and Disposition June 2002, 30 (6) 663-669; DOI: https://doi.org/10.1124/dmd.30.6.663

  3. Shader, Richard I.

    1. In Vitro Biotransformation of Sildenafil (Viagra) in the Male Rat: The Role of CYP2C11
      Jill S. Warrington, Lisa L. von Moltke, Richard I. Shader and David J. Greenblatt
      Drug Metabolism and Disposition June 2002, 30 (6) 655-657; DOI: https://doi.org/10.1124/dmd.30.6.655

  4. Shou, Magang

    1. Inhibition Kinetics of Monoclonal Antibodies against Cytochromes P450
      Qin Mei, Cuyue Tang, Yuh Lin, Thomas H. Rushmore and Magang Shou
      Drug Metabolism and Disposition June 2002, 30 (6) 701-708; DOI: https://doi.org/10.1124/dmd.30.6.701

  5. Stevens, Jeffrey C.

    1. Characterization of Raloxifene Glucuronidation in Vitro: Contribution of Intestinal Metabolism to Presystemic Clearance
      Daniel C. Kemp, Peter W. Fan and Jeffrey C. Stevens
      Drug Metabolism and Disposition June 2002, 30 (6) 694-700; DOI: https://doi.org/10.1124/dmd.30.6.694

  6. Swedmark, Stellan

    1. Involvement of Liver Carboxylesterases in the In Vitro Metabolism of Lidocaine
      Stefan E. H. Alexson, Margareta Diczfalusy, Magnus Halldin and Stellan Swedmark
      Drug Metabolism and Disposition June 2002, 30 (6) 643-647; DOI: https://doi.org/10.1124/dmd.30.6.643

T

  1. Takahashi, Yoshiki

    1. Hepatocyte Nuclear Factor-1α Is a Causal Factor Responsible for Interindividual Differences in the Expression of UDP-Glucuronosyltransferase 2B7 mRNA in Human Livers
      Kenji Toide, Yoshiki Takahashi, Hiroshi Yamazaki, Yoshiaki Terauchi, Toshihiko Fujii, Andrew Parkinson and Tetsuya Kamataki
      Drug Metabolism and Disposition June 2002, 30 (6) 613-615; DOI: https://doi.org/10.1124/dmd.30.6.613

  2. Tanaka, Eriko

    1. Imipramine N-Glucuronidation in Human Liver Microsomes: Biphasic Kinetics and Characterization of UDP-Glucuronosyltransferase Isoforms
      Miki Nakajima, Eriko Tanaka, Tomo Kobayashi, Noriko Ohashi, Toshiyuki Kume and Tsuyoshi Yokoi
      Drug Metabolism and Disposition June 2002, 30 (6) 636-642; DOI: https://doi.org/10.1124/dmd.30.6.636

  3. Tang, Cuyue

    1. Effect of Albumin on Phenytoin and Tolbutamide Metabolism in Human Liver Microsomes: An Impact More Than Protein Binding
      Cuyue Tang, Yuh Lin, A. David Rodrigues and Jiunn H. Lin
      Drug Metabolism and Disposition June 2002, 30 (6) 648-654; DOI: https://doi.org/10.1124/dmd.30.6.648
    2. Inhibition Kinetics of Monoclonal Antibodies against Cytochromes P450
      Qin Mei, Cuyue Tang, Yuh Lin, Thomas H. Rushmore and Magang Shou
      Drug Metabolism and Disposition June 2002, 30 (6) 701-708; DOI: https://doi.org/10.1124/dmd.30.6.701

  4. Terauchi, Yoshiaki

    1. Hepatocyte Nuclear Factor-1α Is a Causal Factor Responsible for Interindividual Differences in the Expression of UDP-Glucuronosyltransferase 2B7 mRNA in Human Livers
      Kenji Toide, Yoshiki Takahashi, Hiroshi Yamazaki, Yoshiaki Terauchi, Toshihiko Fujii, Andrew Parkinson and Tetsuya Kamataki
      Drug Metabolism and Disposition June 2002, 30 (6) 613-615; DOI: https://doi.org/10.1124/dmd.30.6.613

  5. Toide, Kenji

    1. Hepatocyte Nuclear Factor-1α Is a Causal Factor Responsible for Interindividual Differences in the Expression of UDP-Glucuronosyltransferase 2B7 mRNA in Human Livers
      Kenji Toide, Yoshiki Takahashi, Hiroshi Yamazaki, Yoshiaki Terauchi, Toshihiko Fujii, Andrew Parkinson and Tetsuya Kamataki
      Drug Metabolism and Disposition June 2002, 30 (6) 613-615; DOI: https://doi.org/10.1124/dmd.30.6.613

  6. Toutain, Pierre-Louis

    1. Intestinal Secretion Is a Major Route for Parent Ivermectin Elimination in the Rat
      Céline M. Laffont, Pierre-Louis Toutain, Michel Alvinerie and Alain Bousquet-Mélou
      Drug Metabolism and Disposition June 2002, 30 (6) 626-630; DOI: https://doi.org/10.1124/dmd.30.6.626

  7. Tyndale, Rachel F.

    1. Metabolism of 18-Methoxycoronaridine, an Ibogaine Analog, to 18-Hydroxycoronaridine by Genetically Variable CYP2C19
      Wenjiang Zhang, Yamini Ramamoorthy, Rachel F. Tyndale, Stanley D. Glick, Isabelle M. Maisonneuve, Martin E. Kuehne and Edward M. Sellers
      Drug Metabolism and Disposition June 2002, 30 (6) 663-669; DOI: https://doi.org/10.1124/dmd.30.6.663

V

  1. von Moltke, Lisa L.

    1. In Vitro Biotransformation of Sildenafil (Viagra) in the Male Rat: The Role of CYP2C11
      Jill S. Warrington, Lisa L. von Moltke, Richard I. Shader and David J. Greenblatt
      Drug Metabolism and Disposition June 2002, 30 (6) 655-657; DOI: https://doi.org/10.1124/dmd.30.6.655

  2. Vyas, Kamlesh P.

    1. The Disposition and Metabolism of Rofecoxib, a Potent and Selective Cyclooxygenase-2 Inhibitor, in Human Subjects
      Rita A. Halpin, Arturo G. Porras, Leslie A. Geer, Margaret R. Davis, Donghui Cui, George A. Doss, Eric Woolf, Donald Musson, Catherine Matthews, Ralph Mazenko, Jules I. Schwartz, Kenneth C. Lasseter, Kamlesh P. Vyas and Thomas A. Baillie
      Drug Metabolism and Disposition June 2002, 30 (6) 684-693; DOI: https://doi.org/10.1124/dmd.30.6.684

W

  1. Wang, Jibo

    1. Quantitative Structure Activity Relationships for the Glucuronidation of Simple Phenols by Expressed Human UGT1A6 and UGT1A9
      Brian T. Ethell, Sean Ekins, Jibo Wang and Brian Burchell
      Drug Metabolism and Disposition June 2002, 30 (6) 734-738; DOI: https://doi.org/10.1124/dmd.30.6.734

  2. Wang, Jun-Sheng

    1. Trimethoprim and Sulfamethoxazole are Selective Inhibitors of CYP2C8 and CYP2C9, Respectively
      Xia Wen, Jun-Sheng Wang, Janne T. Backman, Jouko Laitila and Pertti J. Neuvonen
      Drug Metabolism and Disposition June 2002, 30 (6) 631-635; DOI: https://doi.org/10.1124/dmd.30.6.631

  3. Warrington, Jill S.

    1. In Vitro Biotransformation of Sildenafil (Viagra) in the Male Rat: The Role of CYP2C11
      Jill S. Warrington, Lisa L. von Moltke, Richard I. Shader and David J. Greenblatt
      Drug Metabolism and Disposition June 2002, 30 (6) 655-657; DOI: https://doi.org/10.1124/dmd.30.6.655

  4. Wen, Xia

    1. Trimethoprim and Sulfamethoxazole are Selective Inhibitors of CYP2C8 and CYP2C9, Respectively
      Xia Wen, Jun-Sheng Wang, Janne T. Backman, Jouko Laitila and Pertti J. Neuvonen
      Drug Metabolism and Disposition June 2002, 30 (6) 631-635; DOI: https://doi.org/10.1124/dmd.30.6.631

  5. Woods, James H.

    1. Characterization of Butyrylcholinesterase Antagonism of Cocaine-Induced Hyperactivity
      Lee Koetzner and James H. Woods
      Drug Metabolism and Disposition June 2002, 30 (6) 716-723; DOI: https://doi.org/10.1124/dmd.30.6.716
    2. Characterization of Equine Butyrylcholinesterase Disposition in the Mouse
      Lee Koetzner and James H. Woods
      Drug Metabolism and Disposition June 2002, 30 (6) 724-730; DOI: https://doi.org/10.1124/dmd.30.6.724

  6. Woolf, Eric

    1. The Disposition and Metabolism of Rofecoxib, a Potent and Selective Cyclooxygenase-2 Inhibitor, in Human Subjects
      Rita A. Halpin, Arturo G. Porras, Leslie A. Geer, Margaret R. Davis, Donghui Cui, George A. Doss, Eric Woolf, Donald Musson, Catherine Matthews, Ralph Mazenko, Jules I. Schwartz, Kenneth C. Lasseter, Kamlesh P. Vyas and Thomas A. Baillie
      Drug Metabolism and Disposition June 2002, 30 (6) 684-693; DOI: https://doi.org/10.1124/dmd.30.6.684

Y

  1. Yamazaki, Hiroshi

    1. Hepatocyte Nuclear Factor-1α Is a Causal Factor Responsible for Interindividual Differences in the Expression of UDP-Glucuronosyltransferase 2B7 mRNA in Human Livers
      Kenji Toide, Yoshiki Takahashi, Hiroshi Yamazaki, Yoshiaki Terauchi, Toshihiko Fujii, Andrew Parkinson and Tetsuya Kamataki
      Drug Metabolism and Disposition June 2002, 30 (6) 613-615; DOI: https://doi.org/10.1124/dmd.30.6.613

  2. Ye, Frank

    1. Pharmacokinetics of Sodium Nitrite-Induced Methemoglobinemia in the Rat
      Michael C. Kohn, Ronald L. Melnick, Frank Ye and Christopher J. Portier
      Drug Metabolism and Disposition June 2002, 30 (6) 676-683; DOI: https://doi.org/10.1124/dmd.30.6.676

  3. Yokoi, Tsuyoshi

    1. Imipramine N-Glucuronidation in Human Liver Microsomes: Biphasic Kinetics and Characterization of UDP-Glucuronosyltransferase Isoforms
      Miki Nakajima, Eriko Tanaka, Tomo Kobayashi, Noriko Ohashi, Toshiyuki Kume and Tsuyoshi Yokoi
      Drug Metabolism and Disposition June 2002, 30 (6) 636-642; DOI: https://doi.org/10.1124/dmd.30.6.636

Z

  1. Zhang, Wenjiang

    1. Metabolism of 18-Methoxycoronaridine, an Ibogaine Analog, to 18-Hydroxycoronaridine by Genetically Variable CYP2C19
      Wenjiang Zhang, Yamini Ramamoorthy, Rachel F. Tyndale, Stanley D. Glick, Isabelle M. Maisonneuve, Martin E. Kuehne and Edward M. Sellers
      Drug Metabolism and Disposition June 2002, 30 (6) 663-669; DOI: https://doi.org/10.1124/dmd.30.6.663
Back to top

In this issue